Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms (vol 70, pg 621, 2018) Z Zanos, R Moaddel, PJ Morris, LM Riggs, JN Highland, P Georgiou, ... PHARMACOLOGICAL REVIEWS 70 (4), 879-879, 2018 | 911* | 2018 |
Ketamine and ketamine metabolite pharmacology: insights into therapeutic mechanisms P Zanos, R Moaddel, PJ Morris, LM Riggs, JN Highland, P Georgiou, ... Pharmacological reviews 70 (3), 621-660, 2018 | 911 | 2018 |
(2R, 6R)-hydroxynorketamine exerts mGlu2 receptor-dependent antidepressant actions P Zanos, JN Highland, BW Stewart, P Georgiou, CE Jenne, J Lovett, ... Proceedings of the National Academy of Sciences, 201819540, 2019 | 133 | 2019 |
A negative allosteric modulator for α5 subunit-containing GABA receptors exerts a rapid and persistent antidepressant-like action without the side effects of the NMDA receptor … P Zanos, ME Nelson, JN Highland, SR Krimmel, P Georgiou, TD Gould, ... eneuro 4 (1), 2017 | 100 | 2017 |
Mouse, rat, and dog bioavailability and mouse oral antidepressant efficacy of (2R,6R)-hydroxynorketamine JN Highland, PJ Morris, P Zanos, J Lovett, S Ghosh, AQ Wang, ... Journal of Psychopharmacology 33 (1), 12-24, 2019 | 55 | 2019 |
A Negative Allosteric Modulator for α5 Subunit-Containing GABA Receptors Exerts a Rapid and Persistent Antidepressant-Like Action without the Side Effects of the NMDA Receptor … P Zanos, ME Nelson, JN Highland, SR Krimmel, P Georgiou, TD Gould PubMed Abstract| Publisher Full Text| Free Full Text, 0 | 12* | |
F102. Human Experimenter Sex Modulates Mouse Behavioral Responses to Stress and to the Antidepressant Ketamine P Georgiou, P Zanos, C Jenne, J Highland, D Gerhard, R Duman, T Gould Biological Psychiatry 83 (9), S277, 2018 | 8 | 2018 |
T89. Group II Metabotropic Glutamate Receptor Blockade Promotes Stress Resilience J Highland, P Zanos, P Georgiou, T Gould Biological Psychiatry 83 (9), S163, 2018 | | 2018 |